about
Androgen deprivation therapy in the treatment of advanced prostate cancerLeuprorelin depot injection: patient considerations in the management of prostatic cancerAR, the cell cycle, and prostate cancer.Evaluation of primary androgen deprivation therapy in prostate cancer patients using the J-CAPRA risk score.The AR dependent cell cycle: mechanisms and cancer relevance.Role of maximum androgen blockade in advanced prostate cancer.Efficacy of alternative antiandrogen therapy for prostate cancer that relapsed after initial maximum androgen blockade.
P2860
Q24676531-9108368A-0227-4D1F-B8D6-62E0F01903C4Q36823588-729AA1B0-0901-43E3-957F-199848D8A5C1Q37095260-4E940F6B-2F9D-45FC-A0D7-28D09D2F103CQ37270472-050D78ED-8477-4D12-B9C2-E16E7D104B06Q37904028-E0DF4AD7-9E42-4ABF-97D4-D0784D79DAFEQ39977084-BDE47A76-BD7C-4D7D-8606-5870DFD21AA7Q42857879-679B5F43-1ACE-4BFE-B338-8A26091FE615
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Maximum androgen blockade: a clinical update.
@ast
Maximum androgen blockade: a clinical update.
@en
type
label
Maximum androgen blockade: a clinical update.
@ast
Maximum androgen blockade: a clinical update.
@en
prefLabel
Maximum androgen blockade: a clinical update.
@ast
Maximum androgen blockade: a clinical update.
@en
P2860
P1433
P1476
Maximum androgen blockade: a clinical update
@en
P2093
Gerald W Chodak
P2860
P478
P577
2005-01-01T00:00:00Z